Metabonomic Profiles Discriminate Hepatocellular Carcinoma from Liver Cirrhosis by Ultraperformance Liquid Chromatography–Mass Spectrometry

2012 ◽  
Vol 11 (2) ◽  
pp. 1217-1227 ◽  
Author(s):  
Baohong Wang ◽  
Deying Chen ◽  
Yu Chen ◽  
Zhenhua Hu ◽  
Min Cao ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Hepatocellular Carcinoma ◽  
Liver Cirrhosis ◽  
Liquid Chromatography ◽  
Liquid Chromatography Mass Spectrometry ◽  
Chromatography Mass Spectrometry

Lipidomics analysis based on liquid chromatography mass spectrometry for hepatocellular carcinoma and intrahepatic cholangiocarcinoma

RSC Advances ◽  
2015 ◽  
Vol 5 (78) ◽  
pp. 63711-63718 ◽  
Author(s):  
Qun Liang ◽  
Cong Wang ◽  
Binbing Li ◽  
Ai-hua Zhang
Keyword(s):  
Mass Spectrometry ◽  
Hepatocellular Carcinoma ◽  
Liquid Chromatography ◽  
Sensitivity And Specificity ◽  
Intrahepatic Cholangiocarcinoma ◽  
High Sensitivity ◽  
Liquid Chromatography Mass Spectrometry ◽  
Chromatography Mass Spectrometry

Plasma lipidomics showed that four metabolites, PE(19 : 0/0 : 0), PE(18 : 2(9Z,12Z)/0 : 0), PC(14 : 0/0 : 0) and PC(18 : 0/0 : 0), were defined as biomarkers with high sensitivity and specificity, which can be used to distinguish the HCC and ICC.

Sign in / Sign up

Export Citation Format

Share Document